The pathogenesis of hidradenitis suppurativa: a closer look at apocrine and apoeccrine glands, Br J Dermatol, vol.133, pp.254-262, 1995. ,
Hidradenitis suppurativa/acne inversa: criteria for diagnosis, severity assessment, classification and disease evaluation, Dermatology (Basel), vol.231, pp.184-90, 2015. ,
Quality of Life Group of the French Society of Dermatology. Quality of life impairment in hidradenitis suppurativa: a study of 61 cases, J Am Acad Dermatol, vol.56, pp.621-624, 2007. ,
Hidradenitis suppurativa markedly decreases quality of life and professional activity, J Am Acad Dermatol, vol.62, pp.706-714, 2010. ,
Morbidity in patients with hidradenitis suppurativa, Br J Dermatol, vol.144, pp.809-822, 2001. ,
Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis, J Am Acad Dermatol, vol.71, pp.1144-50, 2014. ,
Clinical practice. Hidradenitis suppurativa, N Engl J Med, vol.366, pp.158-64, 2012. ,
Surgical treatment of Verneuil's disease (hidradenitis suppurativa): 15 cases, Ann Dermatol Venereol, vol.128, pp.127-136, 2001. ,
Incidence of hidradenitis suppurativa and associated factors: a population-based study of Olmsted County, Minnesota, J Invest Dermatol, vol.133, pp.97-103, 2013. ,
Identification of three hidradenitis suppurativa phenotypes: latent class analysis of a cross-sectional study, J Invest Dermatol, vol.133, pp.1506-1517, 2013. ,
Diagnostic delay in hidradenitis suppurativa is a global problem, Br J Dermatol, vol.173, pp.1546-1555, 2015. ,